4Coudron P M, Markowitz S M, Wong E S, et al. Isolate of beta- lactamase-produeing, aminoglyeoside-resistant strain of Entero- coccus faecium[J]. Antimierob Agents Chemother, 1992, 36: 1125-1126.
5Linden P K, Miller C B. Vancomycln-resistant Enterococci: the clinical effect of a common nosocomial pathogen. Diagn Microbi- ol Infect Dis, 1999, 32 (2) : 113-120.
6Maschieto A, Martine R, Palazzo I C, et al. Antimivrobial re- sistance of Enterococcus sp. isolated from the intestinal tract of patients from a university hospital in Brazil[J]. Mere Inst Oswal- do Cruz,2004,99(7) :763-767.
7Moellering Jr Rc. Emergence of Entercoccus as a signficant pathogen[J]. Clin Infect Dis, 1992, 14(6): 1173.
8Murray B E, Lopardo H A, Rubeguo E A, et al. Intrahospital spread of a single gentamicin-resistance, beta-laetamase-produ- cing strain of Enterococcus faecalis in Argentina[J]. Antimicrob Agents Chemother, 1992, 36:230-232.
9Murray P R. Manual of clinical microbiology[M]. 7th Washing- ton D C:Am Soc Microbiol, 1999,297-305.
10Piekarska K, Lawrynowicz-Paciorek M, Magdziak A, et al. Drug sensitivity of Enterococcus sp. strains isolated from clinical material or from healthy persons[J]. Med Dosw Mierobiol, 2002,54(4) : 305-315.
